订阅小程序
旧版功能

Safety and Efficacy of the Investigational Agent Orteronel (TAK-700) Without Prednisone in Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) Patients with Rising Prostate-Specific Antigen (PSA): Updated Results from a Phase 2 Study

UROLOGY(2012)

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要